Literature DB >> 16424248

Asymptomatic central venous stenosis in hemodialysis patients.

Rebecca D Levit1, Raphael M Cohen, Andrew Kwak, Richard D Shlansky-Goldberg, Timothy W I Clark, Aalpen A Patel, S William Stavropoulos, Jeffrey I Mondschein, Jeffrey A Solomon, Catherine M Tuite, Scott O Trerotola.   

Abstract

PURPOSE: To retrospectively evaluate the natural history of high-grade (>50%) asymptomatic central venous stenosis (CVS) in hemodialysis patients and the outcome of serial treatment of CVS with percutaneous transluminal angioplasty (PTA).
MATERIALS AND METHODS: The institutional review board granted exemption for this retrospective study, the need for informed consent was waived, and all data collection was in compliance with HIPAA. Patients with hemodialysis access requiring maintenance procedures between 1998 and 2004 and incidentally found to have ipsilateral (> or =50%) CVS were identified from a departmental database. Thirty-five patients (19 men, 16 women; mean age, 58.7 years) with 38 grafts met inclusion criteria, and 86 venograms were reviewed. CVS was measured by using venograms obtained before and after PTA, if performed. Patients with arm swelling, multiple CVS, indwelling catheters, and stents at the first encounter were excluded. CVS progression was calculated by dividing the change in the degree of stenosis by the time between venographic examinations. Wilcoxon rank sum test was used to evaluate differences in rate of CVS progression between treated and nontreated patients.
RESULTS: Mean degree of CVS before intervention was 71% (range, 50%-100%). Sixty-two percent (53 of 86) of lesions had associated collateral vessels; 28% (24 of 86) of CVSs were not treated. Mean degree of stenosis in this group was 72% (range, 30%-100%); mean progression was -0.08 percentage point per day. No untreated CVS progressed to symptoms, stent placement, or additional CVS. Seventy-two percent (62 of 86) of CVSs were treated with PTA. Mean degree of stenosis in this group was 74% (range, 50%-100%) before and 40% (range, 0%-75%) after treatment; mean progression was 0.21 percentage point per day after treatment (P = .03). Six (8%) of 62 treatments were followed by CVS escalation; one patient developed arm swelling, four required stents, and four developed additional CVS.
CONCLUSION: PTA of asymptomatic CVS greater than 50% in the setting of hemodialysis access maintenance procedures was associated with more rapid stenosis progression and escalation of lesions, compared with a nontreatment approach. Copyright RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16424248     DOI: 10.1148/radiol.2383050119

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  All That Glitters is Not Gold: All Unilateral Oedema is Not DVT.

Authors:  Ashwal Adamane Jayaram; Padmakumar Ramachandran; Tom Devasiya; Abdul Razak Uddina Kumeri; Umesh Pai
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 2.  Stent and Stent-Graft Use in Arteriovenous Dialysis Access.

Authors:  Gordon McLennan
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  Percutaneous intervention in axillary loop-configured arteriovenous grafts for chronic hemodialysis patients.

Authors:  Beom Jin Park; Hyoung Rae Kim; Hwan Hoon Chung; Deuk Jae Sung; Sang Joon Park; Ho Sung Son; Sang Kyung Jo; Yun Hwan Kim; Sung Bum Cho
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

4.  Central vein stenosis in a dialysis patient: a case report.

Authors:  Uwe Gottmann; Maliha Sadick; Kathrin Kleinhuber; Urs Benck; Kurt Huck; Bernhard K Krämer; Rainer Birck
Journal:  J Med Case Rep       Date:  2012-07-09

5.  Brachiocephalic Vein Stenting and Body-Floss Technique as a Treatment of CVD in Dialysis-Dependent Patient - Case Report and Literature Review.

Authors:  Róża Krycińska; Agata Trznadel; Paulina Kuchalska; Michał Lis; Bartosz Dołęga-Kozierowski; Krzysztof Dyś; Stanisław Drelichowski; Wojciech Witkiewicz
Journal:  Pol J Radiol       Date:  2015-05-10

6.  The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients.

Authors:  Yonghui Huang; Bing Chen; Guosheng Tan; Gang Cheng; Yi Zhang; Jiaping Li; Jianyong Yang
Journal:  BMC Cardiovasc Disord       Date:  2016-12-07       Impact factor: 2.298

7.  Endovascular mechanical thrombectomy and stenting in a case of central vein thrombosis.

Authors:  Rajesh Vijayvergiya; Navjyot Kaur; Saroj K Sahoo; Ashish Sharma
Journal:  BMJ Case Rep       Date:  2021-02-18

8.  Recommended Clinical Trial End Points for Dialysis Catheters.

Authors:  Michael Allon; Deborah J Brouwer-Maier; Kenneth Abreo; Kevin M Baskin; Kay Bregel; Deepa H Chand; Andrea M Easom; Leonard Mermel; Michele H Mokrzycki; Priti R Patel; Prabir Roy-Chaudhury; Surendra Shenoy; Rudolph P Valentini; Haimanot Wasse
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

9.  Effectiveness of sharp recanalization of superior vena cava-right atrium junction occlusion.

Authors:  Xiao-Wen Wu; Xu-Ya Zhao; Xing Li; Jun-Xiang Li; Zong-Yang Liu; Zhi Huang; Ling Zhang; Chong-Yang Sima; Yu Huang; Lei Chen; Shi Zhou
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

10.  Endovascular interventions for central vein stenosis.

Authors:  Anil K Agarwal
Journal:  Kidney Res Clin Pract       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.